GFN•TV will bring the conference's platform for rational and inclusive debate on the future role of safer nicotine products and tobacco harm reduction to an audience all year round. GFN•TV will also be broadcasting live from Warsaw in June. Tune in to hear world-leading experts, tobacco harm reduction advocates and nicotine consumers discuss the latest scientific, regulatory and policy developments. From our unique annual event, to year-round reporting of the issues that matter in tobacco harm reduction, GFN has got it covered.
GFN 2024 Keynote #3 given by Vivien Azer, hosted by David Sweanor, response from Jonathan Fell
Vivien is a nicotine market specialist, and until recently, the Managing Director & Senior Analyst, Global Beverages, Tobacco and Cannabis, at TD Cowen, in New York City. In her keynote she will address a number of themes, among them:
- What factors prompted and drove initial investment in this field? - What is the state of the current market? - Who are the major investors/stakeholders? - What might be the impact of regulation – and possible prohibition – on future investment and the - development of the next generation of safer nicotine products? - Are there lessons to be learnt from other emerging markets, for example the market for medicinal and recreational cannabis?
📅 28 Jun 2024
Michael Russell Award 2024 | #GFN24
Michael Russell Award 2024 - presented to Dr. Colin Mendelsohn by Professor Gerry Stimson
📅 25 Jun 2024
Misinterpretation of the precautionary principle in relation to safer nicotine - Keynote #2 | #GFN24
Whilst no activity has a total absence of risk, science has to embrace risks and challenges to evolve. The over/misinterpretation of the precautionary principle is often an impediment to progress. Drawing on his experience of working with dependence in other fields, Dr McGovern will examine, in relation to nicotine use: - How should we categorise/quantify risk? - Is there a hierarchy of risk(s)? - What are the consequences of avoiding all risks? - How can equivalence assist in assessing risk? - Who should determine the limits of risk – for the individual and communities? - Are there lost opportunities for tobacco harm reduction to have a significant impact on personal and societal health improvement, due to the inappropriate application of the precautionary principle?
Health and economic benefits of tobacco harm reduction - Keynote #1 | #GFN24
GFN 2024 Keynote #1 - delivered by Andrzej Fal, response by Michelle Minton - titled "Health and economic benefits of tobacco harm reduction".
- What does the current evidence tell us about the potential health and economic benefits of safer nicotine products? - How should we weight this evidence? - What more do we need to know, what is the prognosis for the future and what are the short and long-term costs of different policy alternatives? - How might legislators and regulators balance health and economic imperatives to achieve positive outcomes? - What factors might make for an effective legislative and regulatory framework? - How should future progress be monitored, and policies adjusted in response?
Michael Russell Oration 2024 - "Bridging the Divide: Taking Global Action to End Smoking" | #GFN24
GFN 2024 Michael Russell Oration - delivered by Cliff Douglas - President and Chief Executive Officer of the Global Action to End Smoking - titled "Bridging the Divide: Taking Global Action to End Smoking"
📅 7 Jun 2024
GFN.TV Interviews | FORGOTTEN FRONTIER | Fighting Risky Forms of Tobacco in LMICs
What’s holding up the transformation to safer nicotine products in low-income and middle-income countries, known as LMICs? In India, there are over 300 million tobacco users, with many using what Dr. Sudhanshu Patwardhan calls “risky forms of tobacco” that significantly increase cancer severity. Hear Dr. Sud’s “bottom of the pyramid” plan to supercharge the tobacco transformation in LMICs.
Featuring: Dr. Sudhanshu Patwardhan Medical Doctor, Nicotine Expert @Doctor_Sud
📅 4 Jun 2024
#GFN24 IN THE SPOTLIGHT | Famous faces of #GFN24 share their hopes for this year's conference!
As #GFN24 draws nearer, we've brought back some famous faces of the Global Forum on Nicotine to share what they're looking forward to at this year's conference. If you can't join us in Warsaw, you can watch selected sessions online for FREE - all you need to do is register! Join us at #GFN24! 👉 https://gfn.events/registration/
Australia intensified its war on vaping with new, punitive regulations that will criminalize nicotine vaping products to an extent unseen in the Western world. The government explicitly states that its goal is to 'reverse the increasing uptake of recreational nicotine.
Featuring:
Fiona Patten Former Member, Parliament of Victoria, Australia Chair, Australian Consumers’ Association Harm Reduction, Vaping Activist @FionaHPatten
📅 28 May 2024
GFN News #113 | IS THIS REALLY THE PATH TO A SMOKEFREE SPAIN? | Featuring Carmen Escrig
Under Spain's new anti-smoking plan, safer nicotine products will now be equated with smoking in the latest measures to restrict vaping in the country. Joining us today is Carmen Escrig, Coordinator of the Spanish Medical Platform for Tobacco Harm Reduction, who will highlight the pushback against this proposal and the institutional biases that helped create it in the first place.
GFN News #112 | BLOOMBERG FUNDING IN SPOTLIGHT IN INDIA | Featuring Samrat Chowdhery
When India's government added nicotine replacement therapies to its list of essential medicines, tobacco harm reduction advocates celebrated a win for smokers looking to quit. But was this success short lived, and has India returned to an anti-nicotine frame of mind? Joining us today to discuss India's track record with nicotine is journalist Samrat Chowdhery.